Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors

Consensus Round Table, Scottsdale (Arizona), March 22, 1987

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Endocrinology & Metabolism, Gastroenterology
Cover of the book Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642613289
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642613289
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.

More books from Springer Berlin Heidelberg

Cover of the book Der Ingenieur als GmbH-Geschäftsführer by
Cover of the book Endosonography in Gastroenterology by
Cover of the book Lipoprotein Metabolism by
Cover of the book Medizinrecht by
Cover of the book Nonlinear Optics in the Filamentation Regime by
Cover of the book The Cox Model and Its Applications by
Cover of the book Außenhandel by
Cover of the book The Crossing of Heaven by
Cover of the book Progress in Fibrin Sealing by
Cover of the book Hair Replacement Surgery by
Cover of the book The Cytochemical Bioassay of Polypeptide Hormones by
Cover of the book Optical Guided-wave Chemical and Biosensors II by
Cover of the book New Diagnostic Methods in Oncology and Hematology by
Cover of the book Waldökologie by
Cover of the book Microbial Degradation of Xenobiotics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy